SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-145194
Filing Date
2021-12-01
Accepted
2021-12-01 07:37:22
Documents
13
Period of Report
2021-12-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2134154d1_8k.htm   iXBRL 8-K 33711
2 EXHIBIT 10.1 tm2134154d1_ex10-1.htm EX-10.1 55143
  Complete submission text file 0001104659-21-145194.txt   278922

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA irwd-20211201.xsd EX-101.SCH 3043
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE irwd-20211201_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE irwd-20211201_pre.xml EX-101.PRE 22371
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2134154d1_8k_htm.xml XML 3627
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34620 | Film No.: 211461376
SIC: 2834 Pharmaceutical Preparations